PMID- 20936992 OWN - NLM STAT- MEDLINE DCOM- 20101207 LR - 20211020 IS - 1532-4303 (Electronic) IS - 0277-0903 (Print) IS - 0277-0903 (Linking) VI - 47 IP - 9 DP - 2010 Nov TI - Exhaled NO among inner-city children in New York City. PG - 1015-21 LID - 10.3109/02770903.2010.513075 [doi] AB - BACKGROUND: Fractional exhaled nitric oxide (FeNO) has been proposed as a biomarker of airway inflammation for cohort studies of asthma. OBJECTIVES: To assess the association between FeNO and asthma symptoms among 7-year-old children living in an inner-city community. To test the association between environmental tobacco smoke (ETS) exposure (previous and current) and FeNO among these children. METHODS: As part of a longitudinal study of asthma, children recruited in Head Start centers at age 4 had offline FeNO and lung function testing at age 7. Children with allergen-specific immunoglobulin E (IgE) (>/=0.35 IU/mL) at age 7 were considered seroatopic. ETS exposure at ages 4 and 7 was assessed by questionnaire. RESULTS: Of 144 participating children, 89 had complete questionnaire data and achieved valid FeNO and lung function tests. Children with reported wheeze in the previous 12 months (n = 19) had higher FeNO than those without wheeze (n = 70) (geometric means 17.0 vs. 11.0 ppb, p = .005). FeNO remained significantly associated with wheeze (p = .031), after adjusting for seroatopy and forced expiratory volume in 1 second (FEV(1)) in multivariable regression. FeNO at age 7 was positively associated with domestic ETS exposure at age 4 (29%) (beta = 0.36, p = .015) but inversely associated with ETS exposure at age 7 (16%) (beta = -0.74, p < .001). CONCLUSIONS: Given its association with current wheeze, independent of seroatopy and lung function, FeNO provides a relevant outcome measure for studies in inner-city communities. While compelling, the positive association between ETS exposure at age 4 and a marker of airway inflammation at age 7 should be confirmed in a larger study. FAU - Perzanowski, Matthew S AU - Perzanowski MS AD - Department of Environmental Health Sciences, Mailman School of Public Health, Columbia University, New York, NY 10032, USA. mp2217@columbia.edu FAU - Divjan, Adnan AU - Divjan A FAU - Mellins, Robert B AU - Mellins RB FAU - Canfield, Stephen M AU - Canfield SM FAU - Rosa, Maria Jose AU - Rosa MJ FAU - Chew, Ginger L AU - Chew GL FAU - Rundle, Andrew AU - Rundle A FAU - Goldstein, Inge F AU - Goldstein IF FAU - Jacobson, Judith S AU - Jacobson JS LA - eng GR - P30 ES009089/ES/NIEHS NIH HHS/United States GR - R01 HL068236/HL/NHLBI NIH HHS/United States GR - HL068236/HL/NHLBI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PL - England TA - J Asthma JT - The Journal of asthma : official journal of the Association for the Care of Asthma JID - 8106454 RN - 0 (Biomarkers) RN - 0 (Tobacco Smoke Pollution) RN - 31C4KY9ESH (Nitric Oxide) RN - 37341-29-0 (Immunoglobulin E) SB - IM MH - Asthma/*diagnosis/physiopathology MH - Biomarkers/analysis MH - Body Mass Index MH - Breath Tests MH - Child MH - Child, Preschool MH - Cohort Studies MH - *Exhalation MH - Female MH - Humans MH - Immunoglobulin E/blood MH - Inhalation Exposure/*adverse effects MH - Longitudinal Studies MH - Male MH - New York City MH - Nitric Oxide/*analysis MH - Poverty MH - Tobacco Smoke Pollution/*analysis MH - Urban Population PMC - PMC3056403 MID - NIHMS268126 COIS- Declaration of Interest: The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper. EDAT- 2010/10/13 06:00 MHDA- 2010/12/14 06:00 PMCR- 2011/11/01 CRDT- 2010/10/13 06:00 PHST- 2010/10/13 06:00 [entrez] PHST- 2010/10/13 06:00 [pubmed] PHST- 2010/12/14 06:00 [medline] PHST- 2011/11/01 00:00 [pmc-release] AID - 10.3109/02770903.2010.513075 [doi] PST - ppublish SO - J Asthma. 2010 Nov;47(9):1015-21. doi: 10.3109/02770903.2010.513075.